FDA Inspection 1085238 — Hercon Pharmaceuticals, LLC

Hercon Pharmaceuticals, LLC — FEI 2522638

The FDA completed an inspection of Hercon Pharmaceuticals, LLC on April 5, 2019 in Emigsville, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 5, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Emigsville, PA (United States)

Citations

IDCFRDescription
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
202721 CFR 211.192Investigations of discrepancies, failures
435321 CFR 211.160(b)(4)Instruments, apparatus, et. al. not meeting specs